COST-EFFECTIVENESS ANALYSIS OF RESMETIROM: AN INVESTIGATIONAL TREATMENT FOR THE MANAGEMENT OF NONALCOHOLIC STEATOHEPATITIS

被引：0
|
作者：
Javanbakht, M. [1 ]
Fishman, J. [2 ]
Moloney, E. [1 ]
Rydqvist, P. [2 ]
Ansaripour, A. [3 ]
机构：
[1] Optimax Access, Southampton, Hants, England
[2] Madrigal Pharmaceut, W Conshohocken, PA USA
[3] Optimax Access, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE313
引用
收藏
页码：S395 / S395
页数：1
相关论文
共 50 条
  • [1] Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis
    Mehdi Javanbakht
    Jesse Fishman
    Eoin Moloney
    Peter Rydqvist
    Amir Ansaripour
    PharmacoEconomics - Open, 2023, 7 : 93 - 110
  • [2] Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis
    Javanbakht, Mehdi
    Fishman, Jesse
    Moloney, Eoin
    Rydqvist, Peter
    Ansaripour, Amir
    PHARMACOECONOMICS-OPEN, 2023, 7 (01) : 93 - 110
  • [3] A SYSTEMATIC LITERATURE REVIEW, NETWORK META-ANALYSIS, AND COST-EFFECTIVENESS ANALYSIS OF RESMETIROM FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
    Ansaripour, A.
    Fishman, J.
    Bowes, K.
    Brown, A.
    Nasserinejad, K.
    Javanbakht, M.
    Ahmadizar, F.
    VALUE IN HEALTH, 2023, 26 (06) : S123 - S123
  • [4] THE IMPACT OF TREATMENT-RELATED CHANGES IN LIPIDS ON THE COST-EFFECTIVENESS OF RESMETIROM AND OBETICHOLIC ACID FOR TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
    Ansaripour, A.
    Fishman, J.
    Moloney, E.
    Javanbakht, M.
    VALUE IN HEALTH, 2023, 26 (06) : S100 - S101
  • [5] Bariatric Surgery for Nonalcoholic Steatohepatitis: A Clinical and Cost-Effectiveness Analysis
    Klebanoff, Matthew J.
    Corey, Kathleen E.
    Chhatwal, Jagpreet
    Kaplan, Lee M.
    Chung, Raymond T.
    Hur, Chin
    HEPATOLOGY, 2017, 65 (04) : 1156 - 1164
  • [6] Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
    Klebanoff, Matthew J.
    Corey, Kathleen E.
    Samur, Sumeyye
    Choi, Jin G.
    Kaplan, Leem.
    Chhatwal, Jagpreet
    Hur, Chin
    JAMA NETWORK OPEN, 2019, 2 (02) : e190047
  • [7] Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis
    Kathleen E. Corey
    Matthew J. Klebanoff
    Angela C. Tramontano
    Raymond T. Chung
    Chin Hur
    Digestive Diseases and Sciences, 2016, 61 : 2108 - 2117
  • [8] Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis
    Corey, Kathleen E.
    Klebanoff, Matthew J.
    Tramontano, Angela C.
    Chung, Raymond T.
    Hur, Chin
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (07) : 2108 - 2117
  • [9] Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence
    Ciardullo, Stefano
    Mantovani, Alessandro
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (06) : 1117 - 1118
  • [10] Long-term Clinical Outcomes and Cost-Effectiveness of Obeticholic Acid for Treatment of Nonalcoholic Steatohepatitis
    Chhatwal, Jagpreet
    Samur, Sumeyye
    Klebanoff, Matthew
    Corey, Kathleen E.
    Banken, Reiner
    Chapman, Richard H.
    Ollendorf, Daniel A.
    Hur, Chin
    HEPATOLOGY, 2016, 64 : 53A - 54A
12345